Two Dosage Strengths of Lupron Depot-PED 3-Month Approved for Central Precocious Puberty - MPR
Links shared publicly online about this topic.
- 65total visits
Two Dosage Strengths of Lupron Depot-PED 3-Month Approved for Central Precocious Puberty - MPR
empr.com —
Abbott announced that the FDA has approved Lupron Depot-PED (leuprolide acetate for depot suspension) 11.25mg and 30mg for three-month administration for the treatment of children with central precocious puberty (CPP).
View full resource at empr.com
Tags: Puberty, Precocious Puberty, Prostate Cancer Medication, Children's Health, FDA, Lupron, Leuplin
Most Recently Shared on August 17, 2011 at 4:45 pm By:
Lupron Depot-PED 3-Month Approved for Central Precocious Puberty http://ow.ly/65wFH #pediatrics
Advertisement
